• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND COMPLETE SE ILIAC; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND COMPLETE SE ILIAC; STENT, ILIAC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Restenosis (4576)
Event Date 07/15/2020
Event Type  Injury  
Manufacturer Narrative
Title: directional atherectomy for treating in-stent restenosis of the superficial femoral artery authors: seung-kee min, ahram han, sang-hyun ahn journal: vascular specialist international year: 2020 vol/issue: 36(3) ref: 0000-0002-1433-2562.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a retrospective cross-sectional study among patients with in-stent restenosis (isr) in the superficial femoral artery (sfa).257 limbs in 253 patients underwent stent insertion for superficial femoral artery lesions.Medtr onic¿s complete se stent was used during treatment.73 limbs of 73 patients were excluded due to multiple lesion in index vessels, previous stenting history in index vessels and follow-up loss after the procedure.The clinical record of 180 patients (184 limbs) was reviewed.29 limbs in 27 patients diagnosed as in-stent restenosis.14 limbs underwent atherectomy followed by balloon angioplasty.15 limbs underwent balloon angioplasty alone.Medtronic¿s silverhawk atherectomy device was used for atherectomy.One patient in the atherectomy group, and 4 patient¿s in the balloon angioplasty group were treated with an inpact admiral.Technical success was achieved in all patients in both groups, and procedural success was achieved in 85.7% of the atherectomy group, and 73.3% of the angioplasty group, with no significant differences.Clinical events of residual stenosis (treated by repeated balloon angioplasty), distal embolization (treated by aspiration embolectomy), and flow-limiting dissection (treated by bailout stenting) are reported as outcomes following treatment.At one-year follow-up target lesion revascularization was carried out across the two groups.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMPLETE SE ILIAC
Type of Device
STENT, ILIAC
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key11025636
MDR Text Key223611595
Report Number9612164-2020-04952
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P110040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2020
Initial Date FDA Received12/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-